Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV000735425 | SCV001366262 | uncertain significance | Mucopolysaccharidosis type 7 | 2020-03-25 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PP3,PM3_SUPP. |
Baylor Genetics | RCV000735425 | SCV001522959 | pathogenic | Mucopolysaccharidosis type 7 | 2020-01-23 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genomic Medicine Center of Excellence, |
RCV000735425 | SCV004800992 | likely pathogenic | Mucopolysaccharidosis type 7 | 2024-02-11 | criteria provided, single submitter | research | |
Fulgent Genetics, |
RCV000735425 | SCV005674373 | pathogenic | Mucopolysaccharidosis type 7 | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Pathology and Clinical Laboratory Medicine, |
RCV000735425 | SCV000854592 | pathogenic | Mucopolysaccharidosis type 7 | 2018-12-03 | no assertion criteria provided | clinical testing | |
Biochemical Molecular Genetic Laboratory, |
RCV000735425 | SCV001469236 | pathogenic | Mucopolysaccharidosis type 7 | 2020-09-10 | no assertion criteria provided | clinical testing |